Immunotherapy has the potential to treat almost any type of cancer. Learn how we are making this a reality for more patients sooner.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
Show your support for CRI and cancer immunotherapy research by wearing white on June 7, attending free webinars, or shopping at 1-800-FLOWERS.COM.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Numerous challenges can derail progress in finding new immune-based cancer treatments. We're solving some of the biggest challenges, keeping promising new immunotherapies on the fast track to patients.
Cancer patients are now beginning to benefit from advances in cancer immunotherapy. Watch this story of hope and survival, and be inspired to help us conquer cancer.
Browse our directory of scientific leaders who volunteer their time and expertise to help ensure that we fund the most innovative and promising research possible.
Welcome to our blog. Here we share the latest updates from CRI, including scientific breakthroughs, news stories, and program announcements. We invite your comments and encourage you to share these stories with your friends.
You can receive notifications of new posts by subscribing to our blog. Just click the RSS icon in the upper right corner.
December 5, 2011
Jill O'Donnell-Tormey, Ph.D.
Lloyd J. Old, the Father of Modern Tumor Immunology and the founding scientific and medical director of the Cancer Research Institute, succumbed to prostate cancer at the age of 78.